|
 |
Volume 3, Number 4 (April 2006) | |||||
Letter from the Editor |
|||||
175 |
Your forum: practical, succinct, timely Wilshire Oncology Medical Group, Inc., La Verne, CA The articles in this issue vary widely in subject, but all offer practical information that you can use in your practice now. A special note: our Web site (www.CommunityOncology.net) now offers an easy way to browse for articles on specific cancers, offering you some key references and colleagues to help guide your care. In this issue you’ll find articles on costs of hospitalizing lung cancer patients, a comprehensive Challenging Cases/Rare Cancers review of malignant mesothelioma, the best options for dealing with a rising PSA after initial treatment for prostate cancer, and more.
|
||||
Community Dialogue |
|||||
185 |
Fulfilling a duty to cancer patients It’s an exciting time in cancer drug development, and Silvana Martino has had a front-row seat, reviewing data on new, targeted drugs such as erlotinib (Tarceva) and weighing in on hot-button issues such as surrogate endpoints for clinical trials. As a seasoned researcher and community oncologist, Dr. Martino understands both the experience of patients and how statistical tricks can hide the truth in data.
|
||||
Community Translations |
|||||
191 |
When PSA levels rise following surgery or radiation therapy Dana-Farber Cancer Institute, Boston, MA What do you do with a patient who has had some form of local therapy for prostate cancer, whether surgery or radiation therapy, and then his prostate-specific antigen level rises? It’s a unique situation, unlike any encountered in managing other solid tumors. The author sheds light on the matter.
|
||||
Economics/Practice Management |
|||||
200 |
Hospitalizations subsequent to the diagnosis of lung cancer: a clinical and financial analysis Comprehensive Cancer Center, Community Hospital of the Monterey Peninsula, Monterey, CA Although repeated hospital admissions are frequent among lung cancer patients throughout the course of their illness, little information is available. The authors assess the clinical and financial aspects of admitting these patients at a community hospital over a 12-month period.
|
||||
Challenging Cases/Rare Cancers |
|||||
215 |
Malignant mesothelioma Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, and NYU Medical Center/School of Medicine, New York, NY Malignant mesothelioma is an aggressive tumor that is increasing in incidence all over the world, even though its incidence has leveled off in the United States. This comprehensive review presents a case history, covers the epidemiology and biology of the disease, its clinical course and diagnosis (including staging), as well as treatment options.
|
||||
First Annual Conference |
|||||
181 |
First Annual Community Oncology Conference held in Washington, DC More than 300 community-based medical oncology professionals attended the conference, which focused on Medicare reform and educational sessions.
| ||||
Brief Communications |
|||||
197 |
Recruiting more elderly patients for clinical trials Memorial Sloan-Kettering Cancer Center, Commack, NY; H. Lee Moffitt Cancer Center, Tampa, FL; and Geriatric Oncology Consortium, Baltimore, MD
| ||||
Technology |
|||||
206 |
Top 10 PDA programs for oncology practices
| ||||
Meetings Highlights |
|||||
225 |
Dealing with rising healthcare costs
| ||||
225 |
Payers look to guidelines to gauge performance
| ||||
227 |
MMA and the law of unintended consequences
| ||||
Washington Update |
|||||
229 |
CMS off-label drug coverage initiative may die a slow death After pushback from cancer organizations, the Centers for Medicare & Medicaid Services may be backing off a plan that would limit off-label use of some drugs to clinical trials.
|
||||
© 2006 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. |
|||||
52 kb